{"id":314,"date":"2022-02-10T18:05:52","date_gmt":"2022-02-10T22:05:52","guid":{"rendered":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/?p=314"},"modified":"2022-02-10T18:05:52","modified_gmt":"2022-02-10T22:05:52","slug":"district-court-of-delaware-rules-for-generic-pharmas-use-of-skinny-label-but-permits-induced-infringement-suit-to-proceed-against-insurer","status":"publish","type":"post","link":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/2022\/02\/10\/district-court-of-delaware-rules-for-generic-pharmas-use-of-skinny-label-but-permits-induced-infringement-suit-to-proceed-against-insurer\/","title":{"rendered":"District Court of Delaware Rules for Generic Pharma&#8217;s Use of Skinny Label, but Permits Induced Infringement Suit to Proceed Against Insurer"},"content":{"rendered":"<p>In the recent opinion of <em>Amarin Pharma v. Hikma Pharms. U.S.<\/em>, the District Court of Delaware dismissed Amarin\u2019s complaint against Hikma for induced infringement of three patents when Hikma used a skinny label to carve out a patented indication. However, the court held that Amarin sufficiently pled to proceed with the complaint against an insurer, Health Net, for induced infringement.<\/p>\n<p>To read the full text of this Duane Morris <em>Alert<\/em>, please <a href=\"https:\/\/www.duanemorris.com\/alerts\/district_court_delaware_rules_generic_pharmas_use_skinny_label_permits_induced_0222.html\" target=\"_blank\" rel=\"noopener\">visit the firm website<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In the recent opinion of Amarin Pharma v. Hikma Pharms. U.S., the District Court of Delaware dismissed Amarin\u2019s complaint against Hikma for induced infringement of three patents when Hikma used a skinny label to carve out a patented indication. However, the court held that Amarin sufficiently pled to proceed with the complaint against an insurer, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/2022\/02\/10\/district-court-of-delaware-rules-for-generic-pharmas-use-of-skinny-label-but-permits-induced-infringement-suit-to-proceed-against-insurer\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;District Court of Delaware Rules for Generic Pharma&#8217;s Use of Skinny Label, but Permits Induced Infringement Suit to Proceed Against Insurer&#8221;<\/span><\/a><\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[560,77,567],"ppma_author":[521],"class_list":["post-314","post","type-post","status-publish","format-standard","hentry","category-general","tag-patent-infringement","tag-pharmaceutical","tag-skinny-label"],"authors":[{"term_id":521,"user_id":6,"is_guest":0,"slug":"duanemorris3","display_name":"Duane Morris","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/843ff6e7a8fe5fc92109b47a45f34b6cf0ea499e6e788db23456c838b0ae6747?s=96&d=blank&r=g","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/314","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/comments?post=314"}],"version-history":[{"count":0,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/314\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/media?parent=314"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/categories?post=314"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/tags?post=314"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/ppma_author?post=314"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}